The weight loss drug Mounjaro has been approved to treat sleep apnea. How does it work?

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup